[144] Dayforce, Inc. SEC Filing
Form 144 notice for DAY (Dayforce, Inc.) reporting proposed sale of restricted common stock. The filer intends to sell 2,000 shares of common stock through Morgan Stanley Smith Barney on 08/15/2025 with an aggregate market value of $107,220. The filing shows the shares were acquired as restricted stock on 02/24/2023 and fully paid the same day. The filer, identified as Stephen H Holdridge in past sales rows, sold a total of 6,000 shares in the past three months across dates 06/03/2025, 06/13/2025 and 07/15/2025 for combined gross proceeds reported in the filing. The number of shares outstanding is listed as 159,692,530, indicating the proposed sale is a very small fraction of the outstanding base.
- Compliance disclosure provided: Form 144 supplies broker, acquisition, and sale details required under Rule 144.
- Restricted shares origin disclosed: Acquisition listed as restricted stock with acquisition and payment date (02/24/2023).
- No 10b5-1 plan date disclosed: The remarks do not show a trading-plan adoption date or instruction that would indicate a pre-authorized plan.
- Recent selling activity: The filer sold 6,000 shares in the past three months, showing ongoing disposals of holdings.
Insights
TL;DR: Routine insider filing disclosing planned sale of restricted shares; size is immaterial relative to outstanding shares.
The Form 144 documents a proposed public sale of 2,000 restricted common shares via a broker on 08/15/2025, acquired 02/24/2023. The filing also discloses multiple recent sales by the same person totaling 6,000 shares in the prior three months, with gross proceeds noted per trade. Relative to the 159.7 million shares outstanding, the filing implies negligible dilution or market impact. This is a compliance disclosure under Rule 144 rather than an operational or financial event for the issuer.
TL;DR: Disclosure appears consistent with Rule 144 requirements; representation on absence of material nonpublic information is included.
The notice includes the required representation that the seller is not aware of undisclosed material adverse information and indicates the securities were restricted stock from the issuer. The filing lists broker details and the acquisition/payment dates, satisfying procedural elements. There is no indication of a trading plan date or 10b5-1 instruction in the remarks. From a governance perspective, this is standard insider reporting without evidence here of atypical timing or regulatory concern.